合成路线1
该中间体在本合成路线中的序号:
(II) This compound can be obtained by several different ways:
1) By condensation of 9,9-dibromo-6-methyl-4-oxo-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidine-3-carboxylic acid (I) with phenylhydrazine (II) by means of N,N-dimethylaniline in DMSO.
2) By a coupling reaction between 6-methyl-4-oxo-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidine-3-carboxylic acid (III) with phenyldiazonium chloride (IV) (prepared with aniline (V), NaNO2 and HCl).
3) The coupling reaction of (IV) with ethyl 6-methyl-4-oxo-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidine 3-carboxylate (VI) gives ethyl 6-methyl-4-oxo-9-(phenylhydrazono)-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidine-3-carboxylate (VII), which is hydrolyzed with NaOH in water.
4) By reaction of ethyl 9-bromo-6-methyl-4-oxo-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidine-3-carboxylate (VIII) with (II) in refluxing ethanol, giving (VII), already obtained.
5) By condensation of ethyl 9-hydroxy-6-methyl-4-oxo-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidine-3-carboxylate (IX) with (II) in refluxing ethanol yielding (VII), already obtained.
【1】
Vasvari-Debreczy, L.; Horvath, A.; Dessy, F.; Hermecz, I.; De Vos, C.; Meszaros, Z.; Rodriguez, L.; Breining, T.; 18. New antiallergic 4H-pyridol[1,2-a]pyrimidin-4-ones. J Med Chem 1982, 25, 10, 1140-45.
|
【2】
Bitter, I.; Breining, T.; Mandi, A.; Szucs, T.; Horvath, A.; Meszaros, Z.; Virag, S.; Hermecz, I.; Vasvari, L.; Nagy, G.; Sebestyen, G. (Chinoin Pharmaceutical and Chemical Works Co., Ltd.); Condensed pyrimidine derivs., their preparation and pharmaceutical compsns. containing them. GB 2011898 . |
【3】
Vasvari, L.; Horvath, A.; Hermecz, I.; Kokosi, J.; Breining, T. (Chinoin Pharmaceutical and Chemical Works Co., Ltd.); 9-Hydrazono-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]-pyrimidine-4-one derivs., their preparation and pharmaceutical compsns. containing them. GB 2051783 . |
【4】
Castaner, J.; Serradell, M.N.; Sneddon, J.M.; Blancafort, P.; UCB-L-140. Drugs Fut 1983, 8, 7, 612.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
36163 |
9,9-dibromo-6-methyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidine-3-carboxylic acid
|
|
C10H10Br2N2O3 |
详情 |
详情
|
(II) |
11818 |
Phenyl hydrazine; 1-Phenylhydrazine
|
100-63-0 |
C6H8N2 |
详情 | 详情
|
(III) |
36162 |
6-methyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidine-3-carboxylic acid
|
|
C10H12N2O3 |
详情 |
详情
|
(IV) |
25897 |
benzenediazonium chloride
|
|
C6H5ClN2 |
详情 |
详情
|
(V) |
12294 |
Aniline; Phenylamine
|
62-53-3 |
C6H7N |
详情 | 详情
|
(VI) |
36161 |
ethyl 6-methyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidine-3-carboxylate
|
|
C12H16N2O3 |
详情 |
详情
|
(VII) |
36160 |
ethyl 6-methyl-4-oxo-9-[(Z)-2-phenylhydrazono]-7,8-dihydro-4H-pyrido[1,2-a]pyrimidine-3(6H)-carboxylate
|
|
C18H20N4O3 |
详情 |
详情
|
(VIII) |
36158 |
ethyl 9-bromo-6-methyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidine-3-carboxylate
|
|
C12H15BrN2O3 |
详情 |
详情
|
(IX) |
36159 |
ethyl 9-hydroxy-6-methyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidine-3-carboxylate
|
|
C12H16N2O4 |
详情 |
详情
|
合成路线2
该中间体在本合成路线中的序号:
(A) The phenylhydrazone of benzaldehyde (I) is obtained in the usual way, phenylhydrazine (A) with benzaldehyde (B), which by reaction with benzoyl chloride (II) gives (C) and further treatment with HCl in an organic solvent results in the substituted hydrazine hydrochloride (III). Finally, this compound is condensed with levulinic acid (IV) at high temperature.
【1】
Francia, E.; Marin, A. (Uriach & Cia S.A.); Procedimiento de obtencion del acido 1-benzoil-2-metilindol-3-acetico. ES 471436 .
|
【2】
Francia, E.; Garcia Rafanell, J.; Delmetacin. Drugs Fut 1983, 8, 9, 764.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(B) |
10498 |
Benzaldehyde;Benzoic aldehyde;Phenylmethanal |
100-52-7 |
C7H6O |
详情 | 详情
|
(A) |
11818 |
Phenyl hydrazine; 1-Phenylhydrazine
|
100-63-0 |
C6H8N2 |
详情 | 详情
|
(I) |
36167 |
benzaldehyde N-phenylhydrazone
|
588-64-7 |
C13H12N2 |
详情 | 详情
|
(II) |
10463 |
Benzoyl chloride
|
98-88-4 |
C7H5ClO |
详情 | 详情
|
(III) |
36169 |
N-phenylbenzohydrazide
|
|
C13H12N2O |
详情 |
详情
|
(IV) |
36170 |
4-oxopentanoic acid
|
123-76-2 |
C5H8O3 |
详情 | 详情
|
(C) |
36168 |
N-phenyl-N'-[(E)-benzylidene]benzohydrazide
|
|
C20H16N2O |
详情 |
详情
|
合成路线3
该中间体在本合成路线中的序号:
(VI) The condensation of aniline (I) with diethyl ethoxymethylenemalonate (II) by heating at 90 C gives diethyl anilinomethylenemalonate (III), which is cyclized to ethyl 4-hydroxyquinoline-3-carboxylate (IV) by heating at 240 C in diphenyl ether-biphenyl. The reaction of (IV) with hot POCl3 affords ethyl 4-chloro-quinoline-3-carboxylate (V), which is finally cyclized with phenylhydrazine (VI) by heating at 105 C in xylene. (VI) is prepared in the usual way starting from aniline (I) by diazotation with NaNO2-HCl to phenyldiazonium chloride (VII), and reduction with SnCl2-HCl.
【1】
Yokoyama, N.; EP 0022078 .
|
【2】
Yokoyama, N.; US 4312870 .
|
【3】
Ritter, B.; Yokoyama, N.; Neubert, A.D.; 2-Arylpyrazolo[4,3-c]quinolin-3-ones: A partial novel agonist and antagonist of benzodiazepines. J Med Chem 1982, 25, 4, 337-339.
|
【4】
Serradell, M.N.; Grau, M.; Castaner, J.; Blancafort, P.; CGS-8216 and CGS-9896. Drugs Fut 1983, 8, 2, 99.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12294 |
Aniline; Phenylamine
|
62-53-3 |
C6H7N |
详情 | 详情
|
(II) |
14088 |
Diethyl ethoxymethylenemalonate; Diethyl 2-(ethoxymethylene)malonate
|
87-13-8 |
C10H16O5 |
详情 | 详情
|
(III) |
35953 |
diethyl 2-(anilinomethylene)malonate
|
|
C14H17NO4 |
详情 |
详情
|
(IV) |
35954 |
ethyl 4-hydroxy-3-quinolinecarboxylate
|
|
C12H11NO3 |
详情 |
详情
|
(V) |
35955 |
ethyl 4-chloro-3-quinolinecarboxylate
|
|
C12H10ClNO2 |
详情 |
详情
|
(VI) |
11818 |
Phenyl hydrazine; 1-Phenylhydrazine
|
100-63-0 |
C6H8N2 |
详情 | 详情
|
(VII) |
25897 |
benzenediazonium chloride
|
|
C6H5ClN2 |
详情 |
详情
|
合成路线4
该中间体在本合成路线中的序号:
(I) By direct cyclization of phenylhydrazine (I) with ethyl acetoacetate (II) in refluxing ethanol.
【1】
Graul, A.; Castaner, J.; Edaravone. Drugs Fut 1996, 21, 10, 1014.
|
【2】
Nishi, H.; Watanabe, T.; Yuki, S.; Morinaka, Y.; Iseki, K.; Sakurai, H. (Mitsubishi Chemical Corp.); Prophylactic and therapeutic agent for circulatory disorders. EP 0208874; JP 1987108814; US 4857542 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11818 |
Phenyl hydrazine; 1-Phenylhydrazine
|
100-63-0 |
C6H8N2 |
详情 | 详情
|
(II) |
11819 |
ethyl acetoacetate; ethyl 3-oxobutanoate;Acetoacetic ester;Ethyl beta-ketobutyrate;ethyl 3-oxobutyrate |
141-97-9 |
C6H10O3 |
详情 | 详情
|
合成路线5
该中间体在本合成路线中的序号:
(II) The synthesis of [14C]-labeled Bay-u-3405 by two closely related ways has been described:
1) [14C]-Labeled aniline (I) is diazotized and reduced with sodium sulfite, yielding the labeled hydrazine (II), which is condensed with the monoketal of cyclohexane-1,4-dione (III) under Fisher's indole synthesis (ZnCl2) to afford the tetrahydrocarbazole (IV). The hydrolysis of (IV) with HCl in THF/water yields 1,2,3,4-tetrahydrocarbazol-3-one (V), which is submitted to a reductive condensation with (S)-1-phenylethylamine (VI) by means of tetrabutylammonium borohydride, yielding preferentially the secondary amine (VII), which, after purification, is dealkylated with ammonium formate and Pd/C to afford 1,2,3,4-tetrahydrocarbazole-3(R)-amine (VIII). The acylation of (VIII) with 4-fluorophenylsulfonyl chloride (IX) gives the corresponding sulfonamide (X), which is condensed with acrylonitrile by means of NaH, yielding 3-[3(R)-(4-fluorophenylsulfonamido)-1,2,3,4-tetrahydrocarbazol-9-yl]pro pionitrile (XI). Finally, this compound is hydrolyzed in the usual way.
2) The condensation of the sulfonamide (X) with methyl acrylate by means of NaH as before gives 3-[3(R)-(4-fluorophenylsulfonamido)-1,2,3,4-tetrahydrocarbazol-9-yl]propionic acid methyl ester (XII), which is finally hydrolyzed in the usual way.
【1】
Pleiss, U.; Radtke, M.; Rosentreter, U.; Boberg, M.; Synthesis of (+)-(3R)-3-(4-fluorophenylsulfonamido)-1,2,3,4-tetrahydro-9-[5,6,7,8,12,13-u-C-14]carbazolepropanoic acid, [C-14]BAY u 3405. J Label Compd Radiopharm 1994, 34, 12, 1207.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
12294 |
Aniline; Phenylamine
|
62-53-3 |
C6H7N |
详情 | 详情
|
(I) |
45117 |
|
|
C6H7N |
详情 |
详情
|
(II) |
11818 |
Phenyl hydrazine; 1-Phenylhydrazine
|
100-63-0 |
C6H8N2 |
详情 | 详情
|
(II) |
45118 |
|
|
C6H8N2 |
详情 |
详情
|
(III) |
11377 |
1,4-Dioxaspiro[4.5]decan-8-one
|
4746-97-8 |
C8H12O3 |
详情 | 详情
|
(IV) |
12297 |
1,2,3,4-Tetrahydrospiro[9H-carbazole-3,2'-1,3-dioxolane]
|
|
C14H15NO2 |
详情 |
详情
|
(IV) |
45119 |
|
|
C14H15NO2 |
详情 |
详情
|
(V) |
12288 |
1,2,4,9-Tetrahydro-3H-carbazol-3-one
|
|
C12H11NO |
详情 |
详情
|
(V) |
45120 |
|
|
C12H11NO |
详情 |
详情
|
(VI) |
20042 |
(1S)-1-phenyl-1-ethanamine; (1S)-1-phenylethylamine
|
|
C8H11N |
详情 |
详情
|
(VII) |
12290 |
N-[(1S)-1-Phenylethyl]-N-[(3R)-2,3,4,9-tetrahydro-1H-carbazol-3-yl]amine; (3R)-N-[(1S)-1-Phenylethyl]-2,3,4,9-tetrahydro-1H-carbazol-3-amine
|
|
C20H22N2 |
详情 |
详情
|
(VII) |
45121 |
|
|
C20H22N2 |
详情 |
详情
|
(VIII) |
12291 |
(3R)-2,3,4,9-Tetrahydro-1H-carbazol-3-ylamine; (3R)-2,3,4,9-Tetrahydro-1H-carbazol-3-amine
|
|
C12H14N2 |
详情 |
详情
|
(VIII) |
45122 |
|
|
C12H14N2 |
详情 |
详情
|
(IX) |
12292 |
4-Fluorobenzenesulfonyl chloride
|
349-88-2 |
C6H4ClFO2S |
详情 | 详情
|
(X) |
12293 |
4-Fluoro-N-[(3R)-2,3,4,9-tetrahydro-1H-carbazol-3-yl]benzenesulfonamide
|
|
C18H17FN2O2S |
详情 |
详情
|
(X) |
45123 |
|
|
C18H17FN2O2S |
详情 |
详情
|
(XI) |
12304 |
N-[(3R)-9-(2-cyanoethyl)-2,3,4,9-tetrahydro-1H-carbazol-3-yl]-4-fluorobenzenesulfonamide
|
|
C21H20FN3O2S |
详情 |
详情
|
(XI) |
45124 |
|
|
C21H20FN3O2S |
详情 |
详情
|
(XII) |
12305 |
methyl 3-((3R)-3-[[(4-fluorophenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-9H-carbazol-9-yl)propanoate
|
|
C22H23FN2O4S |
详情 |
详情
|
(XII) |
45125 |
|
|
C22H23FN2O4S |
详情 |
详情
|
合成路线6
该中间体在本合成路线中的序号:
(II) A new synthesis of FK-1052 has been described:
The cyclization of 2-methylcyclohexane-1,3-dione (I) with phenylhydrazine (II) by means of sulfuric acid in toluene gives 10-methyl-6,7,8,9-tetrahydropyrido[1,2-a]indol-6-one (III), which is condensed with 5-methyl-1-(triphenylmethyl)imidazole-4-carbaldehyde (IV) by means of lithium diisopropylamide (LDA) in THF to yield 7-[hydroxy[5-methyl-1-(triphenylmethyl)imidazol-4-yl]methyl]-10-methyl-6,7,8,9-tetrahydropyrido[1,2-a]indol-6-one (V). The acylation of (V) with acetic anhydride in pyridine affords the corresponding acetate (VI), which by treatment with 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) is converted to the methylene derivative (VII). Finally, this compound is hydrogenated and deprotected by hydrogenolysis with H2 over Pd/C in acetic acid. In order to obtain the (+)-enantiomer, the racemic mixture is treated with (+)-di-p-toluoyl-D-tartaric acid, and the mixture of diastereomeric salts is separated by fractional crystallization. The (+)-enantiomer is obtained by treatment of the corresponding tartrate salt with 2N NaOH. Finally, the (+)-free base is converted to the hydrochloride by treatment with HCl in EtOH and recrystallization from MeOH/ether.
【1】
Ito, K.; Kato, M.; Yamakuni, H.; Nishino, S.; Takasugi, H.; New 5-HT3 (serotonin-3) receptor antagonists. I. Synthesis and structure-activity relationships of pyrido[1,2-a]indoles. Chem Pharm Bull 1994, 42, 12, 2546.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
15504 |
2-methyl-1,3-cyclohexanedione
|
1193-55-1 |
C7H10O2 |
详情 | 详情
|
(II) |
11818 |
Phenyl hydrazine; 1-Phenylhydrazine
|
100-63-0 |
C6H8N2 |
详情 | 详情
|
(III) |
15498 |
10-methyl-8,9-dihydropyrido[1,2-a]indol-6(7H)-one
|
|
C13H13NO |
详情 |
详情
|
(IV) |
15499 |
5-methyl-1-trityl-1H-imidazole-4-carbaldehyde
|
|
C24H20N2O |
详情 |
详情
|
(V) |
15508 |
7-[hydroxy(5-methyl-1-trityl-1H-imidazol-4-yl)methyl]-10-methyl-8,9-dihydropyrido[1,2-a]indol-6(7H)-one
|
|
C37H33N3O2 |
详情 |
详情
|
(VI) |
15501 |
(10-methyl-6-oxo-6,7,8,9-tetrahydropyrido[1,2-a]indol-7-yl)(5-methyl-1-trityl-1H-imidazol-4-yl)methyl acetate
|
|
C39H35N3O3 |
详情 |
详情
|
(VII) |
15502 |
10-methyl-7-[(E)-(5-methyl-1-trityl-1H-imidazol-4-yl)methylidene]-8,9-dihydropyrido[1,2-a]indol-6(7H)-one
|
|
C37H31N3O |
详情 |
详情
|
合成路线7
该中间体在本合成路线中的序号:
(II) The title indolomorphinan derivative was synthesized by Fisher indole synthesis from the known 14-O-ethyl-5-methylnaltrexone (I) and phenylhydrazine hydrochloride (II) in refluxing acetic acid, followed by conversion to the corresponding hydrochloride salt.
【1】
Helv Chim Acta 1993, 76, 476.
|
【2】
Schmidhammer, H. (AstraZeneca plc); New antagonist cpds.. EP 0759922; JP 1998500131; US 6136817; WO 9531463 .
|
【3】
Monory, K.; Daurer, D.; Schmidhammer, H.; Borsodi, A.; Wieser, M.; Traynor, J.R.; Elliott, J.; Synthesis and biological evaluation of 14-alkoxymorphinans. 14. 14-Ethoxy-5-methyl substituted indolomorphinans with delta opioid receptor selectivity. Bioorg Med Chem Lett 1997, 7, 2, 151. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
42229 |
(1R,5R,13R,17S)-4-(cyclopropylmethyl)-17-ethoxy-10-hydroxy-13-methyl-12-oxa-4-azapentacyclo[9.6.1.0(1,13).0(5,17).0(7,18)]octadeca-7(18),8,10-trien-14-one
|
|
C23H29NO4 |
详情 |
详情
|
(II) |
11818 |
Phenyl hydrazine; 1-Phenylhydrazine
|
100-63-0 |
C6H8N2 |
详情 | 详情
|
合成路线8
该中间体在本合成路线中的序号:
(IV) The intermediate amino pyrazole (I) was prepared as follows. Acylation of malononitrile (IV) with acetyl chloride (V) in the presence of Et3N afforded (1-hydroxyethyliden)malononitrile (VI). Subsequent methylation of the hydroxyl group with dimethyl sulfate gave enol ether (VII). Alternatively, malononitrile (IV) was converted to the ethyl enol ether (VIII) by condensation with triethyl orthoacetate in the presence of Ac2O. Cyclization of either (VII) or (VIII) with phenylhydrazine (IX) furnished 5-amino-4-cyano-1-phenylpyrazole (I).
【1】
Hasegawa, H.; et al.; Synthesis of endothelin converting enzyme inhibitors and their structure activity relationships. 21st Symp Med Chem (Nov 28 2001, Kyoto) 2001, Abst 1P-21.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
49117 |
5-amino-3-methyl-1-phenyl-1H-pyrazole-4-carbonitrile
|
|
C11H10N4 |
详情 |
详情
|
(IV) |
11818 |
Phenyl hydrazine; 1-Phenylhydrazine
|
100-63-0 |
C6H8N2 |
详情 | 详情
|
(IV) |
12061 |
Malononitrile
|
109-77-3 |
C3H2N2 |
详情 | 详情
|
(V) |
19273 |
acetyl chloride
|
75-36-5 |
C2H3ClO |
详情 | 详情
|
(VI) |
56569 |
2-(1-hydroxyethylidene)malononitrile
|
|
C5H4N2O |
详情 |
详情
|
(VII) |
56570 |
2-(1-methoxyethylidene)malononitrile
|
|
C6H6N2O |
详情 |
详情
|
(VIII) |
56571 |
2-(1-ethoxyethylidene)malononitrile
|
|
C7H8N2O |
详情 |
详情
|
合成路线9
该中间体在本合成路线中的序号:
(I) The reaction of phenylhydrazine (I) with propionaldehyde (II) gives the corresponding hydrazone (III), which is condensed with phenyldiazoninum chloride (IV) to yield the formazan (V). The cyclization of (V) by means of BF3 in hot acetic acid affords 3-ethyl-1,2,4-benzotriazine (VI), which is finally oxidized to the target dioxide by means of H2O2 and trifluoroacetic anhydride in dichloromethane.
【1】
Kelson, A.B.; et al.; 1,2,4-Benzotriazine 1,4-dioxides. An important class of hypoxic cytotoxins with antitumor activity. Anti-Cancer Drug Des 1998, 13, 6, 575.
|
【2】
Brown, M.J. (Leland Stanford Junior University); Method of tumor treatment. EP 0649658 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11818 |
Phenyl hydrazine; 1-Phenylhydrazine
|
100-63-0 |
C6H8N2 |
详情 | 详情
|
(II) |
15966 |
propionaldehyde
|
123-38-6 |
C3H6O |
详情 | 详情
|
(III) |
25896 |
propanal N-phenylhydrazone
|
|
C9H12N2 |
详情 |
详情
|
(IV) |
25897 |
benzenediazonium chloride
|
|
C6H5ClN2 |
详情 |
详情
|
(V) |
25898 |
1-[(E)-2-phenyldiazenyl]-1-propanone N-phenylhydrazone
|
|
C15H16N4 |
详情 |
详情
|
(VI) |
25899 |
3-ethyl-1,2,4-benzotriazine
|
|
C9H9N3 |
详情 |
详情
|
合成路线10
该中间体在本合成路线中的序号:
(III) The reduction of 3,5-dimethoxybenzoic acid (I) first with Li in liquid NH3 and methanol, and then with LiAlH4 in THF gives 3,5-dimethoxy-1,4-dihydrobenzyl alcohol (II), which is cyclized with phenylhydrazine (III) in refluxing 4% sulfuric acid yielding 2-(hydroxymethyl)-1,2,3,4-tetrahydrocarbazol-4-one (IV). The reaction of (IV) with tosyl chloride in pyridine affords the corresponding tosylate (V), which is finally condensed with 4-(4-fluorobenzoyl)piperidine (VI) in N-methyl-2-pyrrolidone.
【1】
Masaguer, C.F.; Formoso, E.; Raviña, E.; Tristán, H.; Loza, M.I.; Rivas, E.; Fontenla, J.A.; Butyrophenone analogues in the carbazole series: Synthesis and determination of affinities at D2 and 5-HT2A receptors. Bioorg Med Chem Lett 1998, 8, 24, 3571. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
22761 |
3,5-dimethoxybenzoic acid
|
1132-21-4 |
C9H10O4 |
详情 | 详情
|
(II) |
25566 |
(3,5-dimethoxy-2,5-cyclohexadien-1-yl)methanol
|
|
C9H14O3 |
详情 |
详情
|
(III) |
11818 |
Phenyl hydrazine; 1-Phenylhydrazine
|
100-63-0 |
C6H8N2 |
详情 | 详情
|
(IV) |
25567 |
2-(hydroxymethyl)-1,2,3,9-tetrahydro-4H-carbazol-4-one
|
|
C13H13NO2 |
详情 |
详情
|
(V) |
25568 |
(4-oxo-2,3,4,9-tetrahydro-1H-carbazol-2-yl)methyl 4-methylbenzenesulfonate
|
|
C20H19NO4S |
详情 |
详情
|
(VI) |
21497 |
(4-Fluorophenyl)(4-piperidinyl)methanone; 4-(4-Fluorobenzoyl)piperidine; 4-(p-Fluorobenzoyl)piperidine
|
56346-57-7 |
C12H14FNO |
详情 | 详情
|
合成路线11
该中间体在本合成路线中的序号:
(VI) The condensation of 3,5-dimethoxybenzoic acid (I) with 4-(4-fluorobenzoyl)piperidine (II) by means of DCC and HOBT in DMF gives the piperidide (III), which is reduced with LiAlH4 in THF to yield 1-(3,5-dimethoxybenzyl)-4-(4-fluorobenzoyl)piperidine (IV). The reduction of (IV) with Li in liquid ammonia affords the 1,4-dihydro derivative (V), which is finally cyclized with phenylhydrazine (VI) in refluxing aqueous sulfuric acid to provide the target tetrahydrocarbazolone.
【1】
Masaguer, C.F.; Loza, M.I.; Fontenla, J.A.; Brea, J.; Raviña, E.; Tristan, H.; Butyrophenone analogues in the carbazole series as potential atypical antipsychotics: Synthesis and determination of affinities at D2, 5-HT2A, 5-HT2B and 5-HT2C receptors. Eur J Med Chem 2000, 35, 1, 83. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
22761 |
3,5-dimethoxybenzoic acid
|
1132-21-4 |
C9H10O4 |
详情 | 详情
|
(II) |
21497 |
(4-Fluorophenyl)(4-piperidinyl)methanone; 4-(4-Fluorobenzoyl)piperidine; 4-(p-Fluorobenzoyl)piperidine
|
56346-57-7 |
C12H14FNO |
详情 | 详情
|
(III) |
51415 |
(3,5-dimethoxyphenyl)[4-(4-fluorobenzoyl)-1-piperidinyl]methanone
|
|
C21H22FNO4 |
详情 |
详情
|
(IV) |
51416 |
[1-(3,5-dimethoxybenzyl)-4-piperidinyl](4-fluorophenyl)methanone
|
|
C21H24FNO3 |
详情 |
详情
|
(V) |
51417 |
[1-[(3,5-dimethoxy-2,5-cyclohexadien-1-yl)methyl]-4-piperidinyl](4-fluorophenyl)methanone
|
|
C21H26FNO3 |
详情 |
详情
|
(VI) |
11818 |
Phenyl hydrazine; 1-Phenylhydrazine
|
100-63-0 |
C6H8N2 |
详情 | 详情
|
合成路线12
该中间体在本合成路线中的序号:
(III) The reduction of 3,5-dimethoxybenzoic acid (I) first with Li in liquid NH3 and methanol, and then with LiAlH4 in THF gives 3,5-dimethoxy-1,4-dihydrobenzyl alcohol (II), which is cyclized with phenylhydrazine (III) in refluxing 4% sulfuric acid yielding 2-(hydroxymethyl)-1,2,3,4-tetrahydrocarbazol-4-one (IV). The reaction of (IV) with tosyl chloride in pyridine affords the corresponding tosylate (V), which is finally condensed with 4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidine (VI) in N-methyl-2-pyrrolidone.
【1】
Masaguer, C.F.; Formoso, E.; Raviña, E.; Tristán, H.; Loza, M.I.; Rivas, E.; Fontenla, J.A.; Butyrophenone analogues in the carbazole series: Synthesis and determination of affinities at D2 and 5-HT2A receptors. Bioorg Med Chem Lett 1998, 8, 24, 3571. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
22761 |
3,5-dimethoxybenzoic acid
|
1132-21-4 |
C9H10O4 |
详情 | 详情
|
(II) |
25566 |
(3,5-dimethoxy-2,5-cyclohexadien-1-yl)methanol
|
|
C9H14O3 |
详情 |
详情
|
(III) |
11818 |
Phenyl hydrazine; 1-Phenylhydrazine
|
100-63-0 |
C6H8N2 |
详情 | 详情
|
(IV) |
25567 |
2-(hydroxymethyl)-1,2,3,9-tetrahydro-4H-carbazol-4-one
|
|
C13H13NO2 |
详情 |
详情
|
(V) |
25568 |
(4-oxo-2,3,4,9-tetrahydro-1H-carbazol-2-yl)methyl 4-methylbenzenesulfonate
|
|
C20H19NO4S |
详情 |
详情
|
(VI) |
17910 |
6-fluoro-3-(4-piperidinyl)-1,2-benzisoxazole
|
|
C12H13FN2O |
详情 |
详情
|
合成路线13
该中间体在本合成路线中的序号:
(VI) The condensation of 3,5-dimethoxybenzoic acid (I) with 4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidine (II) by means of DCC and HOBT in DMF gives the piperidide (III), which is reduced with LiAlH4 in THF to yield 1-(3,5-dimethoxybenzyl)-4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidine (IV). The reduction of (IV) with Li in liquid ammonia affords the 1,4-dihydro derivative (V), which is finally cyclized with phenylhydrazine (VI) in refluxing aqueous sulfuric acid to provide the target tetrahydrocarbazolone.
【1】
Masaguer, C.F.; Loza, M.I.; Fontenla, J.A.; Brea, J.; Raviña, E.; Tristan, H.; Butyrophenone analogues in the carbazole series as potential atypical antipsychotics: Synthesis and determination of affinities at D2, 5-HT2A, 5-HT2B and 5-HT2C receptors. Eur J Med Chem 2000, 35, 1, 83. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
22761 |
3,5-dimethoxybenzoic acid
|
1132-21-4 |
C9H10O4 |
详情 | 详情
|
(II) |
17910 |
6-fluoro-3-(4-piperidinyl)-1,2-benzisoxazole
|
|
C12H13FN2O |
详情 |
详情
|
(III) |
51420 |
(3,5-dimethoxyphenyl)[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]methanone
|
|
C21H21FN2O4 |
详情 |
详情
|
(IV) |
51418 |
3-[1-(3,5-dimethoxybenzyl)-4-piperidinyl]-6-fluoro-1,2-benzisoxazole; 3-[[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]methyl]-5-methoxyphenyl methyl ether
|
|
C21H23FN2O3 |
详情 |
详情
|
(V) |
51419 |
3-[[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]methyl]-5-methoxy-1,4-cyclohexadien-1-yl methyl ether; 3-[1-[(3,5-dimethoxy-2,5-cyclohexadien-1-yl)methyl]-4-piperidinyl]-6-fluoro-1,2-benzisoxazole
|
|
C21H25FN2O3 |
详情 |
详情
|
(VI) |
11818 |
Phenyl hydrazine; 1-Phenylhydrazine
|
100-63-0 |
C6H8N2 |
详情 | 详情
|
合成路线14
该中间体在本合成路线中的序号:
(IV) The asymetric Michael addition of malonic ester (II) to 2-cyclohexenone (I) catalyzed by (R)-ALB and t-BuOK in THF gives the (R)-enantiomer (III), which is cyclized with phenylhydrazine (IV) in hot acetic acid yielding the tetrahydrocarbazole (V). The protection of (V) with Boc2O, TEA and DMAP in dichloromethane gives protected (VI), which is condensed with acetaldehyde (VII) by means of LDA in THF affording crotonate (VIII). The reduction of the ester group of (VIII) with DIBAL, followed by oxidation with MnO2 gives the corresponding aldehyde (IX), which is reductocondensed with 2-aminoacetaldehyde dimethylacetal (XI) by means of titanium tetraisopropoxide and NaBH4 in toluene/methanol providing adduct (XI). The deprotection of (XI) with TFA and anisole gives the free tetrahydrocarbazole (XII), which is cyclized by means of DDQ in THF yielding the tetracyclic compound (XIII). The reduction of the exocyclic double bond of (XIII) with RhCl(PPh3)3 in benzene/isopropanol affords the (S)-ethyl derivative (XIV), which is treated with Et-SH and BF3/Et2O in dichloromethane to give the thioacetal (XV). Finally, this compound is cyclized with DMTSF, LiAlH4 and Raney-Ni in refluxing ethanol.
【1】
Shimizu, S.; et al.; Catalytic asymmetric synthesis of tubifolidine. J Org Chem 1998, 63, 21, 7547.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
26253 |
2-cyclohexen-1-one;Cyclohex-2-enone;2-cyclohexenone |
930-68-7 |
C6H8O |
详情 | 详情
|
(II) |
19373 |
dimethyl malonate;Methyl malonate;Propanedioic acid dimethyl ester |
108-59-8 |
C5H8O4 |
详情 | 详情
|
(III) |
37225 |
dimethyl 2-[(1R)-3-oxocyclohexyl]malonate
|
|
C11H16O5 |
详情 |
详情
|
(IV) |
11818 |
Phenyl hydrazine; 1-Phenylhydrazine
|
100-63-0 |
C6H8N2 |
详情 | 详情
|
(V) |
37226 |
methyl 2-[(2R)-2,3,4,9-tetrahydro-1H-carbazol-2-yl]acetate
|
|
C15H17NO2 |
详情 |
详情
|
(VI) |
37227 |
tert-butyl (2R)-2-(2-methoxy-2-oxoethyl)-1,2,3,4-tetrahydro-9H-carbazole-9-carboxylate
|
|
C20H25NO4 |
详情 |
详情
|
(VII) |
11974 |
Acetaldehyde
|
75-07-0 |
C2H4O |
详情 | 详情
|
(VIII) |
37228 |
tert-butyl (2R)-2-[(E)-1-(methoxycarbonyl)-1-propenyl]-1,2,3,4-tetrahydro-9H-carbazole-9-carboxylate
|
|
C22H27NO4 |
详情 |
详情
|
(IX) |
37229 |
tert-butyl (2R)-2-[(E)-1-formyl-1-propenyl]-1,2,3,4-tetrahydro-9H-carbazole-9-carboxylate
|
|
C21H25NO3 |
详情 |
详情
|
(X) |
37158 |
ethyl 5-[3-(benzyloxy)-2-formylphenoxy]pentanoate
|
|
C21H24O5 |
详情 |
详情
|
(XI) |
37230 |
tert-butyl (2R)-2-((E)-1-[[(2,2-dimethoxyethyl)amino]methyl]-1-propenyl)-1,2,3,4-tetrahydro-9H-carbazole-9-carboxylate
|
|
C25H36N2O4 |
详情 |
详情
|
(XII) |
37231 |
(E)-N-(2,2-dimethoxyethyl)-2-[(2R)-2,3,4,9-tetrahydro-1H-carbazol-2-yl]-2-buten-1-amine; N-(2,2-dimethoxyethyl)-N-[(E)-2-[(2R)-2,3,4,9-tetrahydro-1H-carbazol-2-yl]-2-butenyl]amine
|
|
C20H28N2O2 |
详情 |
详情
|
(XIII) |
37232 |
2-[(1S,12R)-13-[(E)ethylidene]-9,15-diazatetracyclo[10.3.1.0(2,10).0(3,8)]hexadeca-2(10),3,5,7-tetraen-15-yl]-1-methoxyethyl methyl ether; (1S,12R)-15-(2,2-dimethoxyethyl)-13-[(E)ethylidene]-9,15-diazatetracyclo[10.3.1.0(2,10).0(3,8)]hexadeca-2(10),3,5,7-tetraene |
|
C20H26N2O2 |
详情 |
详情
|
(XIV) |
37233 |
2-[(1S,12R,13S)-13-ethyl-9,15-diazatetracyclo[10.3.1.0(2,10).0(3,8)]hexadeca-2(10),3,5,7-tetraen-15-yl]-1-methoxyethyl methyl ether; (1S,12R,13S)-15-(2,2-dimethoxyethyl)-13-ethyl-9,15-diazatetracyclo[10.3.1.0(2,10).0(3,8)]hexadeca-2(10),3,5,7-tetraene |
|
C20H28N2O2 |
详情 |
详情
|
(XV) |
37234 |
ethyl 2-[(1S,12R,13S)-13-ethyl-9,15-diazatetracyclo[10.3.1.0(2,10).0(3,8)]hexadeca-2(10),3,5,7-tetraen-15-yl]-1-(ethylsulfanyl)ethyl sulfide; (1S,12R,13S)-15-[2,2-bis(ethylsulfanyl)ethyl]-13-ethyl-9,15-diazatetracyclo[10.3.1.0(2,10).0(3,8)]hexadeca-2(10),3,5,7-tetraene |
|
C22H32N2S2 |
详情 |
详情
|
合成路线15
该中间体在本合成路线中的序号:
(VII) By condensation of substituted nicotinamide (VI) with the carbazolyoxymethyl-oxirane (XII) in hot methanol/water.
The intermediates the nicotinamide (VI) and the oxirane (XII) have been obtained as follows:
1.- Nicotinamide (VI): The reaction of 4-hydroxybenzyl alcohol (I) with 2-nitropropane (II) by means of potassium tert-butoxide in hot diglyme gives 4-(2-methyl-2-nitropropyl)phenol (III), which is reduced to the corresponding amino derivative (IV) with H2 over Pd/C in methanol/ethanol/acetic acid. Finally, this compound is condensed with 6-chloronicotinamide (V) by means of K2CO3 in dimethylacetamide/isooctane.
2.- Oxirane (XII): The reaction of phenylhydrazine (VII) with cyclohexane-1,3-dione (VIII) by means of NaHCO3 in isopropanol/water gives the monohydrazone (IX), which is cyclized with hotpolyphosphoric acid yielding the 4-hydroxycarbazole (X). Finally, this compound is condensed with the glycidyl 3-nitrophenylsulfonate (XI) by means of K2CO3 in refluxing acetone.
【1】
Crowell, T.A.; Evrard, D.A.; Jones, C.D.; Muehl, B.S.; Rito, C.J.; Shuker, A.J.; Thorpe, A.J.; Thrasher, K.J. (Eli Lilly and Company); Carbazole analogues as selective B3 adrenergic agonists. EP 0827746; WO 9809625 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
29474 |
4-(hydroxymethyl)phenol; 4-hydroxyphenylmethanol
4-hydroxybenzenemethanol; 4-Hydroxybenzyl alcohol
|
623-05-2 |
C7H8O2 |
详情 | 详情
|
(II) |
21819 |
2-nitropropane
|
79-46-9 |
C3H7NO2 |
详情 | 详情
|
(III) |
29475 |
4-(2-methyl-2-nitropropyl)phenol
|
|
C10H13NO3 |
详情 |
详情
|
(IV) |
29476 |
4-(2-amino-2-methylpropyl)phenol
|
51706-55-9 |
C10H15NO |
详情 | 详情
|
(V) |
29477 |
6-chloronicotinamide
|
6271-78-9 |
C6H5ClN2O |
详情 | 详情
|
(VI) |
29478 |
6-[4-(2-amino-2-methylpropyl)phenoxy]nicotinamide
|
|
C16H19N3O2 |
详情 |
详情
|
(VII) |
11818 |
Phenyl hydrazine; 1-Phenylhydrazine
|
100-63-0 |
C6H8N2 |
详情 | 详情
|
(VIII) |
11244 |
1,3-Cyclohexanedione
|
504-02-9 |
C6H8O2 |
详情 | 详情
|
(IX) |
29479 |
3-hydroxy-2-cyclohexen-1-one N-phenylhydrazone
|
|
C12H14N2O |
详情 |
详情
|
(X) |
29480 |
4-Hydroxycarbazole; 9H-carbazol-4-ol
|
52602-39-8 |
C12H9NO |
详情 | 详情
|
(XI) |
16259 |
(2S)oxiranylmethyl 3-nitrobenzenesulfonate; (S)-(+)-Glycidyl nosylate
|
115314-14-2 |
C9H9NO6S |
详情 | 详情
|
(XII) |
29481 |
9H-carbazol-4-yl (2S)oxiranylmethyl ether; 4-[(2S)oxiranylmethoxy]-9H-carbazole
|
|
C15H13NO2 |
详情 |
详情
|
合成路线16
该中间体在本合成路线中的序号:
(I) The condensation of phenyl hydrazine (I) with the cis N-methyl-perhydroisoindoletrione (II) gave hydrazone (III), which underwent Fischer indole synthesis upon treatment with methanolic H2SO4 to afford the pyrrolocarbazole (IV) as the major regioisomer (1). Reduction of the imide group of (IV) with aluminum hydride, generated from LiAlH4 and H2SO4, provided the corresponding amine as a racemic mixture. Separation of the desired (R,R)-enantiomer was then achieved by chiral HPLC on Chiralcel(R) OJ.
【1】
Berman, B.; Kaufman, J.; Can J Chem 1982, 60, 4, 419-424.
|
【2】
Pitis, P.M.; Carmosin, R.J.; Carson, J.R. (Ortho-McNeil Pharmaceutical, Inc.); Octahydropyrrolo-[3,4-c]carbazoles useful as analgesic agents. US 6063803; WO 9965911 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11818 |
Phenyl hydrazine; 1-Phenylhydrazine
|
100-63-0 |
C6H8N2 |
详情 | 详情
|
(II) |
31525 |
(3aS,7aR)-2-methyltetrahydro-1H-isoindole-1,3,5(2H,4H)-trione
|
|
C9H11NO3 |
详情 |
详情
|
(III) |
31526 |
(3aS,7aR)-2-methyltetrahydro-1H-isoindole-1,3,5(2H,4H)-trione 5-(N-phenylhydrazone)
|
|
C15H17N3O2 |
详情 |
详情
|
(IV) |
31527 |
(3aR,10cR)-2-methyl-4,5,6,10c-tetrahydropyrrolo[3,4-c]carbazole-1,3(2H,3aH)-dione
|
|
C15H14N2O2 |
详情 |
详情
|
合成路线17
该中间体在本合成路线中的序号:
(III) Synthesis of [18F]FEtNTI:
The intermediate 2-(N1-phenylhydrazino)acetic acid ethyl ester (II) has been obtained by two different ways:
1.- By nitrosation of N-phenylglycine ethyl ester (I) with NaNO2 followed by readuction with Zn/acetic acid (low yields).
2.- By condensation of phenylhydrazine (III) with ethyl bromoacetate (IV) by means of an excess of triethylamine.
The cyclization of intermediate (II) with naltrexone (V) by mans of HCl in methanol gives the indolomorphinanylacetic ester (VI), which is benzyl protected at the OH group by means of benzyl bromide and K2CO3 in DMF yielding the benzyl ether (VII). The reduction of the ester group of (VII) with LiAlH4 in THF/toluene afords the indolomorphinanylethanol (VIII), which is treated with tosyl chloride and potassium trimethylsilanolate in toluene to provide the corresponding tosylate (IX). The reaction of (IX) with potassium [18F]fluoride, K2CO3 and Kryptpfix [2.2.2] in hot DMF gives the 18F labeled intermediate (X), which is finally debenzylated by hydrogenation with H2 over Pd/C in DMF/triethylamine.
【1】
Mathews, W.B.; et al.; Synthesis of N1´-([F-18]fluoroethyl)naltrindole ([F-18]FEtNTI): A radioligand for positron emission tomographic studies of delta opioid receptors. J Label Compd Radiopharm 1999, 42, 1, 43. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
25701 |
ethyl 2-anilinoacetate
|
2216-92-4 |
C10H13NO2 |
详情 | 详情
|
(II) |
25702 |
ethyl 2-(1-phenylhydrazino)acetate
|
|
C10H14N2O2 |
详情 |
详情
|
(III) |
11818 |
Phenyl hydrazine; 1-Phenylhydrazine
|
100-63-0 |
C6H8N2 |
详情 | 详情
|
(IV) |
16640 |
Ethyl 2-bromoacetate; Ethyl bromoacetate
|
105-36-2 |
C4H7BrO2 |
详情 | 详情
|
(V) |
25079 |
(1S,5R,13R,17S)-4-(cyclopropylmethyl)-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.0(1,13).0(5,17).0(7,18)]octadeca-7(18),8,10-trien-14-one; Naltrexone
|
16590-41-3 |
C20H23NO4 |
详情 | 详情
|
(VI) |
25704 |
ethyl 2-[(1S,2S,13S,21R)-22-(cyclopropylmethyl)-2,16-dihydroxy-14-oxa-22-azaheptacyclo[13.9.1.0(1,13).0(2,21).0(4,12).0(5,10).0(19,25)]pentacosa-4(12),5,7,9,15(25),16,18-heptaen-11-yl]acetate
|
|
C31H33NO5 |
详情 |
详情
|
(VII) |
25705 |
ethyl 2-[(1S,2S,13S,21R)-16-(benzyloxy)-22-(cyclopropylmethyl)-2-hydroxy-14-oxa-22-azaheptacyclo[13.9.1.0(1,13).0(2,21).0(4,12).0(5,10).0(19,25)]pentacosa-4(12),5,7,9,15(25),16,18-heptaen-11-yl]acetate
|
|
C38H39NO5 |
详情 |
详情
|
(VIII) |
25706 |
(1S,2S,13S,21R)-16-(benzyloxy)-22-(cyclopropylmethyl)-11-(2-hydroxyethyl)-14-oxa-22-azaheptacyclo[13.9.1.0(1,13).0(2,21).0(4,12).0(5,10).0(19,25)]pentacosa-4(12),5,7,9,15(25),16,18-heptaen-2-ol
|
|
C36H37NO4 |
详情 |
详情
|
(IX) |
25707 |
2-[(1S,2S,13S,21R)-16-(benzyloxy)-22-(cyclopropylmethyl)-2-hydroxy-14-oxa-22-azaheptacyclo[13.9.1.0(1,13).0(2,21).0(4,12).0(5,10).0(19,25)]pentacosa-4(12),5,7,9,15(25),16,18-heptaen-11-yl]ethyl 4-methylbenzenesulfonate
|
|
C43H43NO6S |
详情 |
详情
|
(X) |
25708 |
(1S,2S,13S,21R)-16-(benzyloxy)-22-(cyclopropylmethyl)-11-(2-fluoroethyl)-14-oxa-22-azaheptacyclo[13.9.1.0(1,13).0(2,21).0(4,12).0(5,10).0(19,25)]pentacosa-4(12),5,7,9,15(25),16,18-heptaen-2-ol
|
|
C36H36FNO3 |
详情 |
详情
|
(X) |
45358 |
(1S,2S,13S,21R)-16-(benzyloxy)-22-(cyclopropylmethyl)-11-(2-fluoroethyl)-14-oxa-22-azaheptacyclo[13.9.1.0(1,13).0(2,21).0(4,12).0(5,10).0(19,25)]pentacosa-4(12),5,7,9,15(25),16,18-heptaen-2-ol
|
|
C36H36FNO3 |
详情 |
详情
|
合成路线18
该中间体在本合成路线中的序号:
(II) Noroxymorphindole (III) was prepared by Fischer indole synthesis from noroxymorphone (I) and phenylhydrazine (II) under acidic conditions. Alkylation of (III) with 2-methyl-2-propenyl bromide (IV) in the presence of NaHCO3 in DMF afforded the title compound.
【1】
McLamore, S.; et al.; Effect of N-alkyl and N-alkenyl substituents in noroxymorphindole, 17-substituted-6,7-dehydro-4,5alpha-epoxy-3,14-dihydroxy-6,7:2',3'-indolomorphinans on opioid receptor affinity, selectivity, and efficacy. J Med Chem 2001, 44, 9, 1471. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
33927 |
(1S,5R,13R,17S)-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.0(1,13).0(5,17).0(7,18)]octadeca-7(18),8,10-trien-14-one
|
|
C16H17NO4 |
详情 |
详情
|
(II) |
11818 |
Phenyl hydrazine; 1-Phenylhydrazine
|
100-63-0 |
C6H8N2 |
详情 | 详情
|
(III) |
50974 |
(1S,2S,13R,21R)-14-oxa-11,22-diazaheptacyclo[13.9.1.0(1,13).0(2,21).0(4,12).0(5,10).0(19,25)]pentacosa-4(12),5,7,9,15(25),16,18-heptaene-2,16-diol
|
|
C22H20N2O3 |
详情 |
详情
|
(IV) |
40015 |
3-bromo-2-methyl-1-propene
|
1458-98-6 |
C4H7Br |
详情 | 详情
|
合成路线19
该中间体在本合成路线中的序号:
(V) The methylation of 6-chloro-1H-indole-2-carboxylic acid ethyl ester (I) with NaH and Me-I in DMF gives the 1-methylindole derivative (II), which is condensed with 2-chloro-2-oxoacetic acid ethyl ester (III) by means of TiCl4 in dichloroethane to yield 6-chloro-2-[2-(ethoxycarbonyl)-1-methyl-1H-indol-3-yl]-2-oxoacetic acid ethyl ester (IV). The cyclization of (IV) with phenylhydrazine (V) in refluxing acetic acid affords the 7-chloro-5-methyl-4-oxo-3-phenyl-4,5-dihydro-3H-pyridazino[4,5-b]indole-1-carboxylic acid ethyl ester (VI). The reduction of the ester group of (VI) by means of NaBH4 in refluxing THF/methanol affords the hydroxymethyl derivative (VII), which is oxidized with MnO2 in refluxing dichloromethane to provide the corresponding carbaldehyde (VIII). The reaction of (VIII) with p-Toluenesulfonylmethyl isocyanide (TosMIC) and potassium tert-butoxide in dimethoxyethane gives the acetonitrile derivative (IX), which is hydrolyzed with HCl in refluxing methanol to yield the acetate ester derivative (X). Finally, this compound is treated with dimethylamine and trimethylaluminum in toluene to afford the target dimethylacetamide derivative.
【1】
Bartsch, R.; Sevrin, M.; Froissant, J.; Evanno, Y.; Dubois, L.; Marguet, F.; Gille, C. (Sanofi-Synthélabo); 4-Oxo-3,5-dihydro-4H-pyridazino[4,5-b]-indole-1-acetamide derivs., their preparation and their application in therapy. EP 1000063; FR 2766823; JP 2001512122; US 6262045; WO 9906406 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
55771 |
ethyl 6-chloro-1H-indole-2-carboxylate
|
|
C11H10ClNO2 |
详情 |
详情
|
(II) |
55772 |
ethyl 6-chloro-1-methyl-1H-indole-2-carboxylate
|
|
C12H12ClNO2 |
详情 |
详情
|
(III) |
11043 |
Ethyl 2-chloro-2-oxoacetate; Ethyl oxalyl chloride
|
4755-77-5 |
C4H5ClO3 |
详情 | 详情
|
(IV) |
55773 |
ethyl 6-chloro-3-(2-ethoxy-2-oxoacetyl)-1-methyl-1H-indole-2-carboxylate
|
|
C16H16ClNO5 |
详情 |
详情
|
(V) |
11818 |
Phenyl hydrazine; 1-Phenylhydrazine
|
100-63-0 |
C6H8N2 |
详情 | 详情
|
(VI) |
55774 |
ethyl 7-chloro-5-methyl-4-oxo-3-phenyl-4,5-dihydro-3H-pyridazino[4,5-b]indole-1-carboxylate
|
|
C20H16ClN3O3 |
详情 |
详情
|
(VII) |
55775 |
7-chloro-1-(hydroxymethyl)-5-methyl-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indol-4-one
|
|
C18H14ClN3O2 |
详情 |
详情
|
(VIII) |
55776 |
7-chloro-5-methyl-4-oxo-3-phenyl-4,5-dihydro-3H-pyridazino[4,5-b]indole-1-carbaldehyde
|
|
C18H12ClN3O2 |
详情 |
详情
|
(IX) |
55777 |
2-(7-chloro-5-methyl-4-oxo-3-phenyl-4,5-dihydro-3H-pyridazino[4,5-b]indol-1-yl)acetonitrile
|
|
C19H13ClN4O |
详情 |
详情
|
(X) |
55778 |
methyl 2-(7-chloro-5-methyl-4-oxo-3-phenyl-4,5-dihydro-3H-pyridazino[4,5-b]indol-1-yl)acetate
|
|
C20H16ClN3O3 |
详情 |
详情
|
(XI) |
19443 |
N-methylmethanamine; N,N-dimethylamine
|
124-40-3 |
C2H7N |
详情 | 详情
|
合成路线20
该中间体在本合成路线中的序号:
(I) The cyclization of phenylhydrazine (I) with 3-[4-(methylsulfanyl)phenyl]acrylonitrile (II) by means of NaOEt in refluxing ethanol gives the aminopyrazoline (III), which is dehydrogenated by means of MnO2 in dichloromethane to yield the 3-aminopyrazole (IV). The diazotation of (IV) with NaNO2 and HCl in water, followed by a treatment with Cu2Cl2, affords the 3-chloropyrazole (V), which is finally oxidized to the target sulfone by means of MCPBA in dichloromethane.
【1】
Matsuo, M.; Okumura, K.; Ogino, T.; Nakamura, K.; Nishimura, H.; Harada, K.; Hotta, Y.; Tsuji, K. (Fujisawa Pharmaceutical Co., Ltd.); 1,3,5-Trisubstd. pyrazoles for treatment of inflammation. EP 0856000; JP 1999513403; WO 9713755 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
11818 |
Phenyl hydrazine; 1-Phenylhydrazine
|
100-63-0 |
C6H8N2 |
详情 | 详情
|
(II) |
52011 |
(E)-3-[4-(methylsulfanyl)phenyl]-2-propenenitrile
|
|
C10H9NS |
详情 |
详情
|
(III) |
52012 |
5-[4-(methylsulfanyl)phenyl]-1-phenyl-4,5-dihydro-1H-pyrazol-3-amine; 5-[4-(methylsulfanyl)phenyl]-1-phenyl-4,5-dihydro-1H-pyrazol-3-ylamine
|
|
C16H17N3S |
详情 |
详情
|
(IV) |
52013 |
5-[4-(methylsulfanyl)phenyl]-1-phenyl-1H-pyrazol-3-ylamine; 5-[4-(methylsulfanyl)phenyl]-1-phenyl-1H-pyrazol-3-amine
|
|
C16H15N3S |
详情 |
详情
|
(V) |
52014 |
4-(3-chloro-1-phenyl-1H-pyrazol-5-yl)phenyl methyl sulfide; 3-chloro-5-[4-(methylsulfanyl)phenyl]-1-phenyl-1H-pyrazole
|
|
C16H13ClN2S |
详情 |
详情
|